Chandra K Maharjan

13PUBLICATIONS
50CO-AUTHORS
Haematological tumoursMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Gene expression (incl. microarray and other genome-wide approaches)Cancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jul 30, 2026
PROTAC-mediated targeting of IKKβ and NR4A1 for AML therapy.

|Apr 21, 2026
CerS2 Is a Druggable Target in Triple-Negative Breast Cancer.

|Mar 14, 2026
Updates on Clinical Trials and Molecular Characteristics of Locally Advanced and Oligometastatic Renal Cell Carcinoma.

Temitope M Ogunmola, Zeng Jin, Jeremy Kleberg

|Aug 27, 2025
Tissue-Resident Memory T Cells in Cancer Metastasis Control.

Tyler H Montgomery, Anuj P Master, Zeng Jin

|Jul 29, 2025
ANGPTL4: A Comprehensive Review of 25 Years of Research.

Pedro Ramos, Qiongyu Shi, Jeremy Kleberg

|Jun 13, 2025
Targeting Lineage-Specific Functions of NR4A1 for Cancer Immunotherapy.

Jeremy Kleberg, Akhila Nataraj, Yufeng Xiao

Pageof 3

Frequent Collaborators

9 joint publications

Weizhou Zhang

4 joint publications

Dawn E Quelle

3 joint publications

Jeremy Kleberg

3 joint publications

Guangrong Zheng